Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Priorix-Tetra subcutaneous versus intramuscular administration in healthy toddlers
2005-005944-22Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of GSK208136 in measles, mumps, rubella and 1 more (2 arms), sponsored by GSK. Primary endpoint: Seroconversion rate to varicella-zoster virus. Started Dec 2005; status: completed.
02
Drugs
GSK208136
03
Conditions
measlesmumpsrubellachickenpox
Beyond the preview
Go deeper on 2005-005944-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005944-22.